Arabic Arabic English English French French German German

Postoperative expressive aphasia associated with intravenous midazolam administration: a 5-year retrospective case-control study

Journal of International Medical Research, Volume 48, Issue 8, August 2020.
ObjectivesThis study aimed to investigate the epidemiology of intravenous midazolam-induced postoperative expressive aphasia (EA).MethodsThe incidence rate, risk ratio, and contributing factors to intravenous midazolam-induced postoperative EA were analyzed retrospectively in 6756 orthopedic patients. A telephone interview was conducted with patients with EA after surgery.ResultsPatients were allocated to either the midazolam group (n = 6178) or no-midazolam group (n = 578). Twelve patients developed EA in the midazolam group, with an incidence of 0.19%, and no patient developed EA in the no-midazolam group. The mean age of EA patients was 70 years, and 92% were women. Among them, 75% received general anesthesia, and the mean dose of midazolam was 1.8 mg. EA was reversed in nine of 12 (75%) patients within 4 minutes of flumazenil administration, and >60 minutes were required to reverse EA in the other three patients (25%).ConclusionIntravenous midazolam administration for preoperative sedation caused transient EA in 0.19% of patients, especially elderly women who received general anesthesia, and EA could be reversed by flumazenil. Read More

Leave a Reply

Your email address will not be published. Required fields are marked *

Previous Post

Immune reconstitution inflammatory syndrome associated with Pneumocystis pneumonia in a patient with AIDS

Next Post

Anti-Hu-related epilepsy diagnosed after surgical management

Related Posts